Journal
International journal of infectious diseases
Publication Date
11-1-2021
Volume
112
First Page
217
Last Page
226
Document Type
Open Access Publication
DOI
10.1016/j.ijid.2021.09.043
Rights and Permissions
Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021 Nov;112:217-226. doi: 10.1016/j.ijid.2021.09.043. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
Recommended Citation
Weinstock, Leonard B; Brook, Jill B; Walters, Arthur S; Goris, Ashleigh; Afrin, Lawrence B; and Molderings, Gerhard J, "Mast cell activation symptoms are prevalent in Long-COVID." International journal of infectious diseases. 112, 217 - 226. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11394
mmc1.doc (105 kB)
Appendix 1A. Question prototype used for all groups.
mmc2.xlsx (11 kB)
Appendix 1B. Fatigue and quality of life assessments.
mmc3.docx (14 kB)
Appendix 2. Recruitment letter the general population controls.
mmc4.docx (15 kB)
Appendix 3. Recruitment letter to mast cell activation syndrome patients.
mmc5.docx (109 kB)
Appendix 4. Mast cell mediator release syndrome form.
Appendix 1A. Question prototype used for all groups.
mmc2.xlsx (11 kB)
Appendix 1B. Fatigue and quality of life assessments.
mmc3.docx (14 kB)
Appendix 2. Recruitment letter the general population controls.
mmc4.docx (15 kB)
Appendix 3. Recruitment letter to mast cell activation syndrome patients.
mmc5.docx (109 kB)
Appendix 4. Mast cell mediator release syndrome form.
